Zusammenfassung
Im Jahre 2014 erkrankten circa 4100 Männer neu an einem Keimzelltumor (KZT) des Hodens (RKI 2017). Diese Tumorerkrankung gehört bei Männern zu den selteneren Krebskrankheiten. Im Unterschied zu anderen Tumoren betrifft der Hodentumor vor allem jüngere Männer. Bei Männern zwischen 20 und 44 Jahren ist ein KZT mit einem Anteil von etwa 25 % die häufigste maligne Tumordiagnose.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Aaronson, N. K., Mattioli, V., MintonO, W. J., Johansen, C., Dlton, S. O., et al. (2014). Beyond treatment – Psychosocial and behavioral issues in cancer surviorship research and pratice. European Journal of Cancer supplements, 12(1), 54–64.
Ahles, T. A. (2012). Brain vulnerability to chemotherapy toxicities. Psycho-Oncology, 11, 1141–1148.
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012). Cancer- and cancer treatment-associated cognitive change: An update on the state of the science. Clinical Oncology (Royal College of Radiologist), 30(30), 3675–3686.
Albersen, M., Parnham, A., Joniau, S., Sahdev, V., Christodoulidou, M., Castiglione, F., Nigam, R., Malone, P., Freeman, A., Jameson, C., Minhas, S., Ralph, D. J., & Muneer, A. (2017). Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma. Urologic Oncology, 36(4), 141–146.
Bender, J. L., Wiljer, D., To, M. J., Bedard, P. L., Chung, P., Jewett, M. A., Matthew, A., Moore, M., Warde, P., & Gospodarowicz, M. (2012). Testicular cancer survivors’ supportive care needs and use of online support: A cross-sectional survey. Supportive Care in Cancer, 20(11), 2737–2746.
Bissada, N. K. (1987). Penile reconstruction after total penectomy or urethra-sparing total penectomy. Journal of Urology, 137(6), 1173–1175.
Bokemeyer, C., & Schmoll, H. J. (1993). Secondary neoplasms following treatment of malignant germ cell tumors. Journal of Clinical Oncology, 11(9), 1703–1709.
Bokemeyer, C., & Schmoll, H. J. (1995). Treatment of testicular cancer and the development of secondary malignancies. Journal of Clinical Oncology, 13(1), 283–292.
Brydøy, M., Fosså, S. D., Klepp, O., Bremnes, R. M., Wist, E. A., Wentzel-Larsen, T., & Dahl, O. (2005). Paternity following treatment for testicular cancer. Journal of the National Cancer Institute, 97(21), 1580–1588.
Carlson, L.E., & Bultz, B.D. (2008). Mind-body interventions in oncology. Curr Treat Options Oncol 9(2–3), 127–34.
Dahl, A. A., Mykletun, A., & Fosså, S. D. (2005). Quality of life in survivors of testicular cancer. Urologic Oncology, 23(3), 193–200.
D’Ancona, C. A., Botega, N. J., De Moraes, C., Lavoura, N. S., Jr., Santos, J. K., Rodrigues Netto, N., & Jr. (1997). Quality of life after partial penectomy for penile carcinoma. Urology, 50(4), 593–596.
de Boer AGME, Frings-Dresen MHW (2009). Employment and the common cancers: return to work of cancer survivors. Occup Med (Lond), 59(6), 378–80.
Dräger, D. L., Protzel, C., & Hakenberg, O. W. (2017). Identifying Psychosocial Distress and Stressors Using Distress-screening Instruments in Patients With Localized and Advanced Penile Cancer. Clinical Genitourinary Cancer, 15(5), 605–609.
Dräger, D. L., Milerski, S., Sievert, K. D., & Hakenberg, O. W. (2018). Psychosocial effects in patients with penile cancer: A systematic review. Urologe A, 57(4), 444–452.
Dräger, D. L., & Hakenberg, O. W. (2022). Psychosocial stress burden in patients with localized and metastatic testicular cancer (under review).
Dräger, D. L., Sievert, K. D., & Hakenberg, O. W. (2018b). Cross-Sectional Patient-Reported Outcome Measuring of Health-Related Quality of Life With Establishment of Cancer- and Treatment-Specific Functional and Symptom Scales in Patients With Penile Cancer. Clinical Genitourinary Cancer, 16(6), e1215–e1220
Ficarra, V., Righetti, R., D’Amico, A., Pilloni, S., Balzarro, M., Schiavone, D., Malossini, G., & Mobilio, G. (2000). General state of health and psychological well-being in patients after surgery for urological malignant neoplasms. Urologia Internationalis, 65(3), 130–134.
Fosså, S. D., Chen, J., Schonfeld, S. J., McGlynn, K. A., McMaster, M. L., Gail, M. H., & Travis, L. B. (2005). Risk of contralateral testicular cancer: A population-based study of 29,515 U.S. men. Journal of the National Cancer Institute, 97(14), 1056–66
Fosså, S. D., Oldenburg, J., & Dahl, A. A. (2009). Short- and long-term morbidity after treatment for testicular cancer. BJU Int, 104(9 Pt B), 1418–22
Fung, C., Fossa, S. D., Beard, C. J., & Travis, L. B. (2012). Second malignant neoplasms in testicular cancer survivors. Journal of the National Comprehensive Cancer Network, 10(4), 545–556.
Gambachidze, D., Lebacle, C., Maroun, P., Escande, A., Bossi, A., Blanchard, P., Deutsch, E., Haie-Meder, C., & Chargari, C. (2017). Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma. Brachytherapy, 17(1), 221–226.
Garaffa, G., Raheem, A. A., Christopher, N. A., & Ralph, D. J. (2009). Total phallic reconstruction after penile amputation for carcinoma. BJU International, 104(6), 852–856.
Gulino, G., Sasso, F., Palermo, G., D᾿Onofrio, A., Racioppi, M., Sacco, E., Pinto, F., Antonucci, M., D᾿Addessi, A., & Bassi, P. (2013). Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma. Indian Journal Of Urology, 29(2), 119–123.
Hakenberg, O. W., Compérat, E. M., Minhas, S., Necchi, A., Protzel, C., & Watkin, N. (2014). EAU guidelines on penile cancer: 2014 update. European Urology, 67(1), 142–150.
Jankowska, M. (2012). Sexual functioning of testicular cancer surviviors and their partners: A review of literature. Reports of Practical Oncology and Radiotherapy, 17(1), 54–62.
Katz, D. J., Teloken, P., & Shoshany, O. (2017). Male infertility – The other side of the equation. Australian Family Physician, 46(9), 641–646.
Kieffer, J. M., Djajadiningrat, R. S., van Muilekom, E. A., Graafland, N. M., Horenblas, S., & Aaronson, N. K. (2014). Quality of life for patients treated for penile cancer. Journal of Urology, 192(4), 1105–1110.
Krege, S., & Protzel, C. (2021). Hodentumor und Peniskarzinom – Überleben mit Lebensqualität. Der Urologe, 60, 847–853.
Leitlinienprogramm Onkologie. (2020). (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik, Therapie und Nachsorge des Peniskarzinoms, Langversion 1.01 Konsultationsfassung, 2020, AWMF Registernummer: 043-042OL. https://www.leitlinienprogramm-onkologie.de/leitlinien/peniskarzinom/.
Maddineni, S. B., Lau, M. M., & Sangar, V. K. (2009). Identifying the needs of penile cancer sufferers: A systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urology, 9, 8.
Mandelblatt, J. S., Jacobsen, P. B., & Ahles, T. (2014). Cognitive effects of cancer systemic therapy: Implications for the care of older patients and survivors. Journal of Clinical Oncology, 32(24), 2617–2626.
Marrit, A. T., Hoekstra, H. J., Sleijfer, D. T., Joke, F., Damon, J. V., Gritz, E. R., & Hoekstra-Weebers, J. E. H. M. (2007). Testicular cancer: A longitudinal pilot study on stress response and quality of life in 340 couples before and after chemotherapy. Support Cancer Care, 15(3), 279–286.
Mehnert, A. (2011). Employment and work-related issues in cancer surviors. Crit Rev Oncol Haematol, 77(2), 109–30.
Mortensen, G. L., & Jakobsen, J. K. (2013). Patient perspectives on quality of life after penile cancer. Danish Medical Journal, 60(7), A4655.
Moynihan, C., Bliss, J. M., Davidson, J., Burchell, L., & Horwich, A. (1998). Evaluation of adjuvant psychological therapy in patients with testicular cancer: Randomised controlled trial. BMJ, 316(7129), 429–435.
Noll, K. R., Bradshaw, M. E., Rexer, J., & Wefel, J. S. (2018). Neuropsychological Practice in the Oncology Setting. Archives of Clinical Neuropsychology, 33(3), 344–353.
Opjordsmoen, S., Waehre, H., Aass, N., & Fossa, S. D. (1994). Sexuality in patients treated for penile cancer: Patients᾿ experience and doctors᾿ judgement. British Journal of Urology, 73(5), 554–560.
Parkin, D. M., Whelan, S. L., Ferlay, J., et al. (2002). Cancer incidence in five continents, No 155. IARC Scientific Publication.
Protzel, C., & Hakenberg, O. W. (2018). Local treatment of penile cancer. Urologe A., 57(4), 423–427.
Roiner, M., Maurer, O., Lebentrau, S., Gilfrich, C., Schäfer, C., Haberl, C., Brookman-May, S. D., Burger, M., May, M., & Hakenberg, O. W. (2018). Management of penile cancer patients: New aspects of a rare tumour entity. Aktuelle Urologie, 49(3), 242–249.
Romero, F. R., Romero, K. R., Mattos, M. A., Garcia, C. R., Fernandes Rde, C., & Perez, M. D. (2005). Sexual function after partial penectomy for penile cancer. Urology, 66(6), 1292–1295.
Sansalone, S., Silvani, M., Leonardi, R., Vespasiani, G., & Iacovelli, V. (2017). Sexual outcomes after partial penectomy for penile cancer: Results from a multi-institutional study. Asian Journal of Andrology, 19(1), 57–61.
Scherwath, A., Poppelweis, M., Weis, J., Schulze-Kindermann, F., Koch, U., & Mehnert, A. (2013). Psychometrische Überprüfung einer neuropsychologischen Testbatterie zur Erfassung kognitiver Dysfunktion bei Krebspatienten – Empfehlungen für ein Basisassessment. Fortschritte der Neurologie – Psychiatrie 76(10), 583–593.
Smith, B. S., King, M., Butow, P., Luckett, T., Grimison, P., & Toner, G. C. (2013). The prevalence and correlates of supportive care needs in testicular cancer surviviors: A cross-sectional study. Psycho-Oncology, 22(11), 2557–2564.
Soffietti, R., Trevisan, E., & Rudà, R. (2014). Neurologic complications of chemotherapy and other newer and experimental approaches. Handbook of Clinical Neurology, 121, 1199–1218.
Sohn, M., Dietrich, M., Wirthmann, A., & Rieger, U. M. (2018). Reconstructive surgery in penile cancer. Urologe A, 57(4), 428–434.
Sosnowski, R., Kulpa, M., Kosowicz, M., Wolski, J. K., Kuczkiewicz, O., Moskal, K., Szymański, M., Kalinowski, T., & Demkow, T. (2016). Quality of life in penile carcinoma patients – post-total penectomy. Cent European J Urol, 69(2), 204–211.
Soussain, C., Ricard, D., Fike, J. R., Mazeron, J. J., Psimaras, D., & Delattre, J. Y. (2009). CNS complications of radiotherapy and chemotherapy. Lancet, 374(9701), 1639–1651.
Syse, A., Kravdal, O., & Tretli, S. (2007). Parenthood after cancer – a population-based study. Psycho-Oncology, 16(10), 920–927.
Törnäva, M., Harju, E., Vasarainen, H., Pakarainen, T., Perttilä, I., & Kaipia, A. (2022). Men᾿s experiences of the impact of penile cancer surgery on their lives: A qualitative study. European Journal of Cancer Care, e13548
Travis, L. B., Fosså, S. D., Schonfeld, S. J., McMaster, M. L., Lynch, C. F., Storm, H., Hall, P., Holowaty, E., Andersen, A., Pukkala, E., Andersson, M., Kaijser, M., Gospodarowicz, M., Joensuu, T., Cohen, R. J., Boice, J. D., Jr., Dores, G. M., & Gilbert, E. S. (2005). Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors. Journal of the National Cancer Institute, 97(18), 1354–1365.
Vehling, S., Mehnert, A., Hartmann, M., Oing, C., Bokemeyer, C., & Oechsle, K. (2016). Anxiety and depression in long-term testicular germ cell tumor survivors. General Hospital Psychiatry, 38, 21–25.
Verhoeven, R. H., Janssen-Heijnen, M. L., Saum, K. U., Zanetti, R., Caldarella, A., Holleczek, B., Brewster, D. H., Hakulinen, T., Horenblas, S., Brenner, H., & Gondos, A. EUNICE Survival Working Group. (2013). Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. European Journal of Cancer, 49(6), 1414–1421
Vidrine, D. J., Hoekstra-Weebers, J. E., Hoekstra, H. J., Tuinman, M. A., Marani, S., & Gritz, E. R. (2010). The effects of testicular cancer treatment on health-related quality of life. Urology, 75(3), 636–641.
Virasoro, R., Tonkin, J. B., Mc Cammon, K. A., et al. (2007). Penile amputation: Cosmetic and funtional results. Sex Med Rev, 3, 214–222.
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004a). ‚Chemobrain‛ in breast carcinoma? a prologue. Cancer, 101(3), 466–475.
Wefel, J. S., Kayl, A. E., & Meyers, C. A. (2004b). Neuropsychological dysfunction associated with cancer and cancer therapies: A conceptual review of an emerging target. British Journal of Cancer, 90(9), 1691–1696.
Weis, J., & Faller, H. (2012). Psychosocial issues of long-term cancer survivors. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 55(4), 501–508.
Windahl, T., Skeppner, E., Andersson, S. O., & Fugl-Meyer, K. S. (2004). Sexual function and satisfaction in men after laser treatment for penile carcinoma. Journal of Urology, 172(2), 648–651.
Wischmann, T., Schilling, K., Toth, B., Rösner, S., Strowitzki, T., Wohlfarth, K., & Kentenich, H. (2014). Sexuality, Self-Esteem and Partnership Quality in Infertile Women and Men. Geburtshilfe und Frauenheilkunde, 74(8), 759–763.
Zentrum für Krebsregisterdaten Krebs (www.krebsdaten.de)
Zraik, I. M., & Heß-Busch, Y. (2021). Management von Nebenwirkungen der Chemotherapie und deren Langzeitfolgen. Der Urologe, 60, 862–871.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this chapter
Cite this chapter
Dräger, DL., Hakenberg, O. (2022). Karzinome des äußeren Genitale. In: Berberich, H.J., Dräger, DL. (eds) Psychosoziale Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-65091-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-65091-2_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-65090-5
Online ISBN: 978-3-662-65091-2
eBook Packages: Medicine (German Language)